Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden · Delayed Price · Currency is SEK 80.10
+1.60 (2.04%)
Oct 20, 2026, 10:06 AM CET
STO:IBT.B Market Cap
STO:IBT.B has a market cap or net worth of 1.08 billion as of October 19, 2026. It is the 24,775th most valuable company in the world and the 308th biggest in Sweden. Its market cap has increased by 27.14% in one year.
Market Cap
1.08B
Enterprise Value
970.46M
Revenue
n/a
Global Rank
Country Rank
#308 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since March 29, 2016, STO:IBT.B's market cap has increased from 187.49M to 1.08B, an increase of 475.53%. That is a compound annual growth rate of 18.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 1.08B | 58.61% |
| Dec 30, 2025 | 680.31M | -5.78% |
| Dec 30, 2024 | 722.07M | -40.44% |
| Dec 29, 2023 | 1.21B | 116.00% |
| Dec 30, 2022 | 561.31M | -25.15% |
| Dec 30, 2021 | 749.91M | -40.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 2.48B |
| BioInvent International AB | 1.54B |
| Saniona AB | 1.40B |
| Genovis AB (publ.) | 1.38B |
| Flerie AB | 1.32B |
| AlzeCure Pharma AB | 979.07M |
| SynAct Pharma AB | 951.97M |
| Medivir AB | 904.85M |